John C. Reed - Feb 15, 2024 Form 4 Insider Report for JOHNSON & JOHNSON (JNJ)

Role
EVP, Innovative Medicine, R&D
Signature
/s/ Raavi Deol, as attorney-in-fact for John C. Reed
Stock symbol
JNJ
Transactions as of
Feb 15, 2024
Transactions value $
$0
Form type
4
Date filed
2/20/2024, 05:55 PM
Previous filing
May 2, 2023
Next filing
Oct 31, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction JNJ Employee Stock Options (Right to Buy) Award $0 +65.2K $0.00 65.2K Feb 15, 2024 Common Stock 65.2K $157.92 Direct F1
transaction JNJ Restricted Share Units Award $0 +4.05K $0.00 4.05K Feb 15, 2024 Common Stock 4.05K Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Awarded under Issuer's Long-Term Incentive Plan. The Stock Option Award vests in three equal annual installments beginning on the first anniversary of the grant date.
F2 Awarded under Issuer's Long-Term Incentive Plan. Each Restricted Share Unit represents a contingent right to acquire one share of Common Stock.
F3 The Restricted Share Units vest in three equal annual installments beginning on the first anniversary of the grant date.